Clinical Trial Update: Effect Aflibercept on Ocular Perfusion [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the effect of aflibercept on ocular perfusion in macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Augenabteilung Allgemeines Krankenhaus Linz | Conditions: Macular Degeneration, Anti Vascular Endothelial Growth Factor | Phase 4 | Status: COMPLETED